Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles S Grob

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Psychoactive Drugs|April 15, 2003
The politics of EcstasyCharles S Grob
Forensic Science International|February 7, 2018
Is LSD toxic?David E Nichols, Charles S Grob
Scientific American|December 15, 2010
Hallucinogens as medicineRoland R Griffths, Charles S Grob
Journal of Psychoactive Drugs|September 10, 2005
Ayahuasca use in cross-cultural perspectiveMarlene Dobkin de Rios, Charles S Grob
The American Journal of Psychiatry|January 1, 2025
Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy ResearchKelley C O'Donnell, Jim Grigsby, Charles S Grob
The Lancet. Psychiatry|September 19, 2020
Psychedelic medicine: safety and ethical concernsBrian T Anderson, Alicia L Danforth, Charles S Grob
The Lancet. Psychiatry|April 13, 2016
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMAMichael C Mithoefer, Charles S Grob, Timothy D Brewerton
Journal of the American Academy of Child and Adolescent Psychiatry|May 11, 2024
Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With CautionJessica K Jeffrey, Marc J Weintraub, Charles S Grob
The American Journal of Psychiatry|January 29, 2005
Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalitiesLinda Chang, Thomas Ernst, Oliver Speck, et al.
Journal of Psychoactive Drugs|May 17, 2014
PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis ProgramGeorge R Greer, Charles S Grob, Adam L Halberstadt
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Psychoactive Drugs|April 15, 2003
The politics of EcstasyCharles S Grob
Forensic Science International|February 7, 2018
Is LSD toxic?David E Nichols, Charles S Grob
Scientific American|December 15, 2010
Hallucinogens as medicineRoland R Griffths, Charles S Grob
Journal of Psychoactive Drugs|September 10, 2005
Ayahuasca use in cross-cultural perspectiveMarlene Dobkin de Rios, Charles S Grob
The American Journal of Psychiatry|January 1, 2025
Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy ResearchKelley C O'Donnell, Jim Grigsby, Charles S Grob
The Lancet. Psychiatry|September 19, 2020
Psychedelic medicine: safety and ethical concernsBrian T Anderson, Alicia L Danforth, Charles S Grob
The Lancet. Psychiatry|April 13, 2016
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMAMichael C Mithoefer, Charles S Grob, Timothy D Brewerton
Journal of the American Academy of Child and Adolescent Psychiatry|May 11, 2024
Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With CautionJessica K Jeffrey, Marc J Weintraub, Charles S Grob
The American Journal of Psychiatry|January 29, 2005
Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalitiesLinda Chang, Thomas Ernst, Oliver Speck, et al.
Journal of Psychoactive Drugs|May 17, 2014
PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis ProgramGeorge R Greer, Charles S Grob, Adam L Halberstadt
Pageof 4